Arsano Medical Group, the largest and fastest-growing private healthcare group in the Adria region and a portfolio company of Provectus Capital Partners (PCP), has completed the acquisition of Prima Nova, a leading specialised polyclinic focused on occupational medicine, sports medicine and preventive healthcare services. The transaction marks another important milestone in Arsano Medical Group’s strategy to broaden its specialist medical offering and further strengthen its position as the region’s leading integrated private healthcare platform.
Prima Nova is a well-established and highly regarded polyclinic with deep expertise in occupational and sports medicine, as well as preventive healthcare. Through its strong emphasis on high-quality, targeted medical services, Prima Nova has built a solid reputation for professional excellence, reliability and patient-centred care, serving both individual patients and corporate clients.
With this acquisition, Arsano Medical Group gains an experienced multidisciplinary medical team, established know-how and long-standing relationships with employers and patients. Integrating Prima Nova’s capabilities will enable the Group to further enhance its comprehensive diagnostic, preventive and specialist services across its expanding network of clinics. Member institutions within Arsano Medical Group benefit from strong professional, infrastructural and operational support, as well as a stable platform that enables sustainable, long-term development.
“Prima Nova is an institution with decades of experience and consistently high professional standards,” said Boris Rivić, CEO of Arsano Medical Group, commenting on the transaction. “Its integration significantly strengthens our offering in occupational and sports medicine and supports our vision of building an integrated, accessible and high-quality healthcare system for patients and corporate partners across the region.”
The acquisition is also seen as a key step forward for Prima Nova itself. “Joining Arsano Medical Group represents an important milestone for our institution,” said Damir Todorić, MD, founder of Prima Nova. “It provides the stability, support and investment needed for further growth, while allowing us to preserve the values, expertise and quality of care that define our work.”
Arsano Medical Group is owned by Provectus Capital Partners, a private equity fund focused on supporting scalable, high-quality businesses in the region. Provectus Capital Partners continues to actively back Arsano Medical Group’s long-term growth strategy, including the expansion of its service portfolio and the development of a leading integrated healthcare platform across the Adria market.